Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Book/Monograph Hochschulschrift |
| Sprache: | Englisch |
| Veröffentlicht: |
Heidelberg
2020
|
| DOI: | 10.11588/heidok.00022968 |
| Schlagworte: | |
| Online-Zugang: | Resolving-System, kostenfrei: https://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-229686 Resolving-System, kostenfrei: http://dx.doi.org/10.11588/heidok.00022968 Verlag, kostenfrei, Volltext: http://www.ub.uni-heidelberg.de/archiv/22968 Resolving-System: https://nbn-resolving.org/urn:nbn:de:bsz:16-heidok-229686 Langzeitarchivierung Nationalbibliothek: https://d-nb.info/1211090434/34 Resolving-System: https://doi.org/10.11588/heidok.00022968 
|
| Verfasserangaben: | presented by M.Sc. (Biotechnology) Katharina Deborah Aichelin, born in Heidelberg ; Referees: Prof. Dr. Peter Angel [und ein weiterer Gutachter] |
MARC
| LEADER | 00000cam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1698983379 | ||
| 003 | DE-627 | ||
| 005 | 20230905070837.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200528r20202017gw |||||om 00| ||eng c | ||
| 016 | 7 | |a 1211090434 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bsz:16-heidok-229686 |2 urn | |
| 024 | 7 | |a 10.11588/heidok.00022968 |2 doi | |
| 035 | |a (DE-627)1698983379 | ||
| 035 | |a (DE-599)KXP1698983379 | ||
| 035 | |a (OCoLC)1155636538 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XA-DE-BW | ||
| 082 | 0 | |a 616.079 |q DE-101 | |
| 082 | 0 | 4 | |a 610 |q DE-101 |
| 084 | |a 32 |2 sdnb | ||
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.81 |2 bkl | ||
| 100 | 1 | |a Aichelin, Katharina |e VerfasserIn |0 (DE-588)1211128326 |0 (DE-627)1698984766 |4 aut | |
| 245 | 1 | 0 | |a Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma |c presented by M.Sc. (Biotechnology) Katharina Deborah Aichelin, born in Heidelberg ; Referees: Prof. Dr. Peter Angel [und ein weiterer Gutachter] |
| 264 | 1 | |a Heidelberg |c 2020 | |
| 300 | |a 1 Online-Ressource (XII, 108 Seiten) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 502 | |b Dissertation |c Ruperto-Carola University of Heidelberg |d 2017 | ||
| 534 | |c 2017 | ||
| 546 | |a Text Englisch, Zusammenfassung in deutscher und englischer Sprache | ||
| 655 | 7 | |a Hochschulschrift |0 (DE-588)4113937-9 |0 (DE-627)105825778 |0 (DE-576)209480580 |2 gnd-content | |
| 700 | 1 | |a Angel, Peter |e AkademischeR BetreuerIn |0 (DE-588)1080056572 |0 (DE-627)843623179 |0 (DE-576)453297668 |4 dgs | |
| 751 | |a Heidelberg |0 (DE-588)4023996-2 |0 (DE-627)106300814 |0 (DE-576)208952578 |4 uvp | ||
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Aichelin, Katharina |t Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma |d Heidelberg, 2017 |h XII, 108 Seiten |w (DE-627)172557974X |
| 856 | 4 | 0 | |u https://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-229686 |q application/pdf |x Resolving-System |z kostenfrei |
| 856 | 4 | 0 | |u http://dx.doi.org/10.11588/heidok.00022968 |x Resolving-System |z kostenfrei |
| 856 | 4 | 0 | |u http://www.ub.uni-heidelberg.de/archiv/22968 |q application/pdf |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bsz:16-heidok-229686 |v 2020-06-04 |x Resolving-System |
| 856 | 4 | 0 | |u https://d-nb.info/1211090434/34 |v 2020-06-04 |x Langzeitarchivierung Nationalbibliothek |
| 856 | 4 | 0 | |u https://doi.org/10.11588/heidok.00022968 |v 2020-06-04 |x Resolving-System |
| 912 | |a GBV-ODiss | ||
| 936 | b | k | |a 44.38 |j Pharmakologie |0 (DE-627)106409743 |
| 936 | b | k | |a 44.81 |j Onkologie |0 (DE-627)106409433 |
| 951 | |a BO | ||
| 992 | |a 20200528 | ||
| 993 | |a Thesis | ||
| 994 | |a 2017 | ||
| 998 | |g 1211128326 |a Aichelin, Katharina |m 1211128326:Aichelin, Katharina |d 140000 |d 140001 |e 140000PA1211128326 |e 140001PA1211128326 |k 0/140000/ |k 1/140000/140001/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1698983379 |e 3673829076 | ||
| BIB | |a Y | ||
| JSO | |a {"id":{"uri":["urn:nbn:de:bsz:16-heidok-229686"],"doi":["10.11588/heidok.00022968"],"eki":["1698983379"]},"physDesc":[{"extent":"1 Online-Ressource (XII, 108 Seiten)"}],"title":[{"title":"Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma","title_sort":"Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma"}],"type":{"media":"Online-Ressource","bibl":"thesis"},"noteThesis":["Dissertation. - Ruperto-Carola University of Heidelberg. - 2017"],"origin":[{"dateIssuedDisp":"2020","publisherPlace":"Heidelberg","dateIssuedKey":"2020"}],"language":["eng"],"name":{"displayForm":["presented by M.Sc. (Biotechnology) Katharina Deborah Aichelin, born in Heidelberg ; Referees: Prof. Dr. Peter Angel [und ein weiterer Gutachter]"]},"person":[{"role":"aut","family":"Aichelin","display":"Aichelin, Katharina","given":"Katharina"},{"role":"dgs","family":"Angel","given":"Peter","display":"Angel, Peter"}],"recId":"1698983379"} | ||
| SRT | |a AICHELINKADEVELOPMEN2020 | ||